View of the Renin-Angiotensin System in Acute Kidney Injury Induced by Renal Ischemia-Reperfusion Injury

J Renin Angiotensin Aldosterone Syst. 2022 Oct 22:2022:9800838. doi: 10.1155/2022/9800838. eCollection 2022.

Abstract

Renal ischemia-reperfusion injury (RIRI) is a sequence of complicated events that is defined as a reduction of the blood supply followed by reperfusion. RIRI is the leading cause of acute kidney injury (AKI). Among the diverse mediators that take part in RIRI-induced AKI, the renin-angiotensin system (RAS) plays an important role via conventional (angiotensinogen, renin, angiotensin-converting enzyme (ACE), angiotensin (Ang) II, and Ang II type 1 receptor (AT1R)) and nonconventional (ACE2, Ang 1-7, Ang 1-9, AT2 receptor (AT2R), and Mas receptor (MasR)) axes. RIRI alters the balance of both axes so that RAS can affect RIRI-induced AKI. In overall, the alteration of Ang II/AT1R and AKI by RIRI is important to consider. This review has looked for the effects and interactions of RAS activities during RIRI conditions.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury*
  • Angiotensin II / metabolism
  • Angiotensin-Converting Enzyme 2
  • Humans
  • Kidney / metabolism
  • Peptidyl-Dipeptidase A / metabolism
  • Renin-Angiotensin System
  • Reperfusion Injury* / metabolism

Substances

  • Angiotensin-Converting Enzyme 2
  • Peptidyl-Dipeptidase A
  • Angiotensin II